Computed Tomography Market Size & Share, by Device Portability (Fixed Systems, Portable/Mobile Systems); Architecture; End user; Technology; System Type; Application - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2026-2035

Computed Tomography Market - Regional Analysis

North America Market Insights

North America market is dominating and is expected to hold the revenue share of 35.4% by 2035. The market is dominated by the replacement demand and technological adoption. The primary drivers of the market are the strong healthcare spending and advanced infrastructure that facilitates rapid uptake of premium systems such as photon counting and spectral CT. The key trends include the strategic shift of procedures to outpatient settings such as ambulatory surgical centers, driven by the U.S. reimbursement policies from the CMS. Both robust regulatory frameworks from the FDA and Health Canada focus on dose optimization, pushing healthcare providers to replace aging equipment with newer, safer, and more efficient models. The market growth is further sustained by high volumes in oncology and cardiology imaging, supported by established screening programs and an aging population.

The U.S. computed tomography (CT) market is shaped by the dual forces of patient safety regulation and technology-led upgrade cycles. The recent evidence from UC San Francisco in April 2025 estimates that CT scans could account for up to 5% of annual cancer cases, with 103,000 projected cancers linked to 93 million scans in 2023, which is intensifying scrutiny on radiation exposure, mainly in pediatrics and high-frequency adult imaging. Rather than suppressing demand, this is surging the replacement and retrofit activity as hospitals move toward low-dose AI-enabled systems that meet evolving FDA guidance on imaging safety. This regulatory climate directly supports market momentum as seen in Canon Medical’s March 2025 U.S. clearance for AI-enhanced CT innovations that expand access to dose optimization and image quality tools across major care settings.

The Canada computed tomography market is being shaped by the rapid utilization growth and uneven imaging capacity across regions, creating a clear demand signal for system expansion and replacement. The data from the CDA-AMC in October 2025 show that CT and MRI use in Canada has nearly doubled since 2007, with CT sites now performing an average of 16,350 examinations per year and 12,900 scans per unit, indicating sustained pressure on existing imaging fleets. The study highlights a pronounced urban-rural capacity gap where urban CT sites average 23,036 scans annually compared with 8,303 in rural and 5,999 in remote locations, a disparity that is increasingly driving the public investment in regional imaging access and mobile or satellite CT services. In parallel, academic hospitals averaging 29,024 CT exams per site are emerging as key upgrade markets for high-throughput systems, while community hospitals represent steady volume opportunities for mid-range replacements.

APAC Market Insights

Asia Pacific is the fastest-growing market and is expected to grow at a CAGR of 6.8% during the forecast period 2026 to 2035. The market is driven by massive government healthcare investment, rising medical tourism, and the increasing prevalence of chronic diseases. The growth is diversified in mature markets such as Japan and South Korea, and demand is fueled by the replacement of aging systems with premium AI-integrated spectral and photon-counting CT scanners. In high-growth economies such as China and India, the expansion is driven by the large-scale public health initiatives to install basic and mid-range CTs, aiming to improve access. A key regional trend is the rise of strong domestic manufacturers such as China’s United Imaging and India’s Trivitron, which are competing on cost and offering custom solutions.

China computed tomography (CT) market is entering a technology-driven expansion phase, underscored by the 2025 approval of Neusoft Medical Systems. NeuViz P10 photon counting CT, by the National Medical Products Administration the first system of its kind cleared in the country. This milestone positions China not only as a major consumer but also as a source of next-gen CT innovation stimulation, domestic replacement demand in tertiary hospitals and research centers seeking ultra-high resolution, low-dose imaging. The approval aligns with national healthcare modernization priorities under policy such as Healthy China 2030, which highlights advanced diagnostics, early disease detection, and reduced radiation exposure. The country is advancing with the improvement in the imaging capacity across provincial and country-level hospitals. Photon counting technology is expected to catalyze a premium segment within the CT market, supporting higher system values, strong local manufacturing competitiveness, and increased export potential of Chinese-made CT platforms into emerging markets.

India is experiencing a transformative growth and is primarily driven by the government’s dual strategy of expanding public healthcare access and aggressively promoting domestic manufacturing. Flagship initiatives such as Ayushman Bharat are establishing thousands of new health and wellness centers, creating a massive demand for diagnostic imaging. Further, the production-linked incentive scheme for medical devices is catalyzing local production to reduce the heavy import dependency. This policy-driven environment is shifting market dynamics with domestic and international manufacturers setting up local assembly lines to cater to the demand for cost-effective rugged systems suitable for high-volume, varied infrastructure settings.

List of Approved Companies under the PLI Scheme

Source: CCI August 2024

Europe Market Insights

The universal need for advanced diagnostic tools amid an aging population and the high prevalence of chronic diseases such as cancer and cardiovascular conditions are driving the Europe computed tomography market. The market is mature with growth primarily fueled by the replacement of aging equipment with new, more dose-efficient and technologically advanced systems. The key trends include the strong centralization of procurement in public healthcare systems and robust regulatory harmonization under the EU’s new Medical Device Regulation. The market witnesses a significant rise in demand and is driven in part by coordinated investments such as the EU4Health programme, which allocated a significant amount to strengthen health systems' resilience, including diagnostic infrastructure.

Germany computed topography market is one of the most structurally strong in Europe supported by its position as the largest medical device market in the region and the third largest globally with annual medical technology revenues of approximately USD 44 billion accounting for 26.5% of the Europe market, based on ITA August 2025. Healthcare contributes 12.8% of Germany’s GDP with USD 496 billion in gross value added in 2024 creating a stable funding base for hospital infrastructure and diagnostic imaging investment. Further, the country’s advanced manufacturing ecosystems strengthens the market exemplified by Siemens Healthineers photon counting CT systems developed domestically and widely exported with the U.S. accountign for 40% of shipments. The trade flows underline the central role in imaging equipment supply chains with USD 9.82 billion in imports of optical and medical apparatus in 2023 including USD 3.17 billion in medical instruments from the U.S. Together the healthcare speding and trade data position Germany as the core demand and innovation hub in the Europe computed tomography (CT) market.

The UK computed tomography market is being shaped by sustained pressure across the NHS, which is driving stimulated demand for diagnostic imaging capacity, faster scan turnaround, and system upgrades. According to the NHS December 2024 data, the A&E attendances in England reached 2.36 million, the highest October on record, while the emergency admissions rose to 567,000, intensifying reliance on rapid CT imaging in emergency and acute care pathways. At the same time, diagnostic backlogs remain a policy priority thought the share of patients waiting over 6 weeks for tests improved to 22.7% in September 2024. Volumes continue to rise as cancer referrals and GP appointments hit record levels, with 1.68 million GP appointments per working day. These pressures are translating into stronger procurement of high-throughput CT systems, AI-enabled workflow solutions, and mobile imaging units as NHS trusts seek to expand capacity, shorten cancer and emergency pathways, and improve winter resilience, positioning the UK as the top CT market over the coming years.